Stephanie Atoyebi, DPM
Foot & Ankle Surgery · Chicago, ILNPI 1548826571
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 20.7%. 2025 is the largest year on record at $1,828, 8.8 times the $207 reported in 2020.
Across 69 payments — averaging $57.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lightbody Medical Technologies Inc$821
- Treace Medical Concepts, Inc.$589
- Arthrex$485
- Amgen$472
- Mimedx Group, Inc.$373
- Stryker$311
- plus $915 from 10 others
Across 4 payments — averaging $27,770 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Royal Biologics, Inc.$111K
What the payments were for
- Consulting fees$3008%
- Travel & lodging$1,39435%
- Food & beverage$2,27357%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lightbody Medical Technologies Inc | 5 | $821 |
| Treace Medical Concepts, Inc. | 8 | $589 |
| Arthrex | 7 | $485 |
| Amgen(2 entities) | 13 | $472 |
| Mimedx Group, Inc. | 6 | $373 |
| Stryker | 9 | $311 |
| Galt Pharmaceuticals, LLC | 1 | $300 |
| Abbott | 5 | $185 |
| Convatec Inc. | 2 | $135 |
| Medtronic | 2 | $93 |
| Paragon 28, Inc. | 4 | $90 |
| Organogenesis Inc. | 3 | $52 |
| Smith+Nephew | 1 | $22 |
| Bioventus LLC | 1 | $19 |
| Polynovo North America LLC | 1 | $14 |
| Medartis Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$396
- Orphengesic Forte$300
- KRYSTEXXA$276
- PROCLAIM$135
- InnovaMatrix AC$104
How this compares
$3,967 in reported general payments places this provider in the 60th percentile of 555 foot & ankle surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 22 | $426 |
| Clotrimazole | 19 | $272 |
| Gabapentin | 16 | $84 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Chicago
- Edgardo Rodriguez CollazoChicago$755K
- Stephanie OexemanChicago$206K
- Jeffrey AlexanderChicago$158K
- Matthew GaroufalisChicago$151K
- George HolmesChicago$134K
- Milap PatelChicago$52K
- Theodore PolizosChicago$47K
- Simon LeeChicago$34K
- Wonyong LeeChicago$23K
- Kamran HamidChicago$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.